More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$301047107
EPS
-0.38
P/E ratio
--
Price to sales
208.66
Dividend yield
--
Beta
3.269958
Previous close
$1.33
Today's open
$1.37
Day's range
$1.30 - $1.38
52 week range
$0.69 - $1.81
show more
CEO
Jeffrey Hawkins
Employees
145
Headquarters
Branford, CT
Exchange
NASDAQ Global Market
Shares outstanding
219742414
Issue type
Common Stock
Healthcare
Biotechnology & Life Sciences
Quantum-Si Q3 Earnings Call Highlights
Quantum-Si NASDAQ: QSI reported lower third-quarter revenue and narrowed its net loss as it prepared for the planned second-quarter 2027 commercial launch of its Proteus protein sequencing platform.
MarketBeat • Nov 6, 2026

Quantum-Si incorporated (QSI) Q3 2026 Earnings Call Transcript
Quantum-Si incorporated (QSI) Q3 2026 Earnings Call Transcript
Seeking Alpha • Nov 6, 2026

Quantum-Si Reports Third Quarter 2026 Financial Results and Provides Business Update
BRANFORD, Conn., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule protein sequencing, today announced financial results for the third quarter ended September 30, 2026.
GlobeNewsWire • Nov 5, 2026

Quantum-Si Incorporated (QSI) Reports Q3 Loss, Misses Revenue Estimates
Quantum-Si Incorporated (QSI) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.17 per share a year ago.
Zacks Investment Research • Nov 6, 2026

Quantum-Si to Provide a Business Update and Report Third Quarter 2026 Financial Results on November 5, 2026
BRANFORD, Conn., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will provide a business update and report financial results for the third quarter 2026 on Thursday, November 5, 2026.
GlobeNewsWire • Oct 16, 2026

Quantum-Si Regains Compliance with Nasdaq Minimum Bid Price Requirement
BRANFORD, Conn., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI,” or the “Company”), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that it has received written notice from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Global Market under Listing Rule 5450(a)(1).
GlobeNewsWire • Oct 15, 2026

Leading Indicators For The October Breakout Cycle
Q4 historically delivers outsized S&P 500 returns, especially following midterm election years, supporting the 'October breakout cycle' thesis. Since 2000, the gains in the fourth quarter have averaged more than half of the S&P 500's annual returns with more positive years than all the other quarters. Small cap healthcare/biotech, technology, and consumer cyclicals—like PRME, CRNC, and FOSL—are highlighted as early breakout candidates with strong institutional interest and analyst targets.
Seeking Alpha • Oct 11, 2026

Beyond Elon Musk's Neuralink: Two Public Stocks With a Stake in the Brain Race
Elon Musk's Neuralink is giving us a glimpse of a future in which the human brain can communicate directly with computers. For investors, there's just one problem: You can't buy Neuralink stock.
InvestorPlace • Oct 9, 2026

Quantum-Si Demonstrates Detection of 19 Amino Acids in Proteus™ Development Program
BRANFORD, Conn., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that it has demonstrated detection of 19 amino acids in its Proteus™ development program and is now working to deploy that capability into a developmental sequencing kit for routine use on integrated Proteus instruments.
GlobeNewsWire • Oct 8, 2026

Top 3 Health Care Stocks That May Collapse In Q4
As of Oct. 5, 2026, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Benzinga • Oct 5, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Quantum-Si Incorporated commission-free¹. Build wealth for the long term using automated trading and transfers.